Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

The guidelines suggest using various treatments, including antidepressants and steroids, for alopecia areata and discuss the condition's genetic and immune aspects.

Pulse corticosteroids help regrow hair in alopecia areata but have side effects, especially betamethasone.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Alopecia Areata is an unpredictable autoimmune hair loss condition with limited and variable treatment effectiveness.

Alopecia areata often starts around age 23, can be permanent in 30% of cases, and treatments are usually temporary.

Allergies, especially both seasonal and food, increase the risk of developing alopecia areata.

Atopic dermatitis in kids with alopecia areata can predict poor response to topical immunotherapy.

Alopecia areata is caused by the immune system attacking hair follicles.

Minoxidil helps hair regrowth in alopecia patients, with 16 having good results and no side effects.

People with alopecia areata often have lower vitamin D levels, which may be linked to the condition's severity.

Tofacitinib treatment for hair loss may worsen acne.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

A woman's hair loss condition got worse after her varicose vein treatment with a specific foam.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

Alopecia areata is often linked to personal or family history of allergies and autoimmune diseases.

Platelet-rich plasma therapy is a safe and effective treatment for alopecia areata.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

Tofacitinib, a hair regrowth treatment, may worsen acne.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Contact immunotherapy can improve hair regrowth in alopecia areata patients.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Alopecia areata patients have higher oxidative stress and lower antioxidant levels.

Vitamin A affects hair loss and immune response in alopecia areata.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

Alopecia areata is an autoimmune disease with genetic roots, and treatments include specific topical therapies.